12454106

Source:http://linkedlifedata.com/resource/pubmed/id/12454106

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:12454106	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:12454106	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:12454106	lifeskim:mentions	umls-concept:C0684249	lld:lifeskim
pubmed-article:12454106	lifeskim:mentions	umls-concept:C0332174	lld:lifeskim
pubmed-article:12454106	lifeskim:mentions	umls-concept:C0442027	lld:lifeskim
pubmed-article:12454106	lifeskim:mentions	umls-concept:C0010592	lld:lifeskim
pubmed-article:12454106	lifeskim:mentions	umls-concept:C0144576	lld:lifeskim
pubmed-article:12454106	lifeskim:mentions	umls-concept:C0205390	lld:lifeskim
pubmed-article:12454106	lifeskim:mentions	umls-concept:C0205464	lld:lifeskim
pubmed-article:12454106	lifeskim:mentions	umls-concept:C2603343	lld:lifeskim
pubmed-article:12454106	lifeskim:mentions	umls-concept:C0205179	lld:lifeskim
pubmed-article:12454106	pubmed:dateCreated	2002-11-27	lld:pubmed
pubmed-article:12454106	pubmed:abstractText	A phase II study was performed to assess the efficacy and toxicity of oral cyclosporine (CsA) plus paclitaxel in advanced non-small-cell lung cancer (NSCLC).	lld:pubmed
pubmed-article:12454106	pubmed:language	eng	lld:pubmed
pubmed-article:12454106	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:12454106	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:12454106	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:12454106	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:12454106	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:12454106	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:12454106	pubmed:author	pubmed-author:MarcusSS	lld:pubmed
pubmed-article:12454106	pubmed:author	pubmed-author:ScheulenM EME	lld:pubmed
pubmed-article:12454106	pubmed:author	pubmed-author:MezgerJJ	lld:pubmed
pubmed-article:12454106	pubmed:author	pubmed-author:BaasPP	lld:pubmed
pubmed-article:12454106	pubmed:author	pubmed-author:van...	lld:pubmed
pubmed-article:12454106	pubmed:author	pubmed-author:BeijnenJ HJH	lld:pubmed
pubmed-article:12454106	pubmed:author	pubmed-author:RosingHH	lld:pubmed
pubmed-article:12454106	pubmed:author	pubmed-author:KeilholzUU	lld:pubmed
pubmed-article:12454106	pubmed:author	pubmed-author:SchellensJ...	lld:pubmed
pubmed-article:12454106	pubmed:author	pubmed-author:KruijtzerC...	lld:pubmed
pubmed-article:12454106	pubmed:author	pubmed-author:MathôtR A ARA	lld:pubmed
pubmed-article:12454106	pubmed:owner	NLM	lld:pubmed
pubmed-article:12454106	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:12454106	pubmed:pagination	4508-16	lld:pubmed
pubmed-article:12454106	pubmed:dateRevised	2006-4-24	lld:pubmed
pubmed-article:12454106	pubmed:articleTitle	Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer.	lld:pubmed
pubmed-article:12454106	pubmed:affiliation	Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:12454106	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:12454106	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:12454106	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:12454106	lld:pubmed